These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36468024)

  • 1. GOLM1 is related to the inflammatory/immune nature of uveal melanoma and acts as a promising indicator for prognosis and immunotherapy response.
    Liang X; Yin Y; Li N
    Front Genet; 2022; 13():1051168. PubMed ID: 36468024
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
    Wang W; Zhao H; Wang S
    Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross talk between tumor stemness and microenvironment for prognosis and immunotherapy of uveal melanoma.
    Wan Q; Ren X; Tang J; Ma K; Deng YP
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11951-11968. PubMed ID: 37420017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAG2 Is a Novel Prognostic Biomarker and Promising Immunotherapy Target in Uveal Melanoma.
    Li C; Shi H
    Crit Rev Eukaryot Gene Expr; 2023; 33(6):55-71. PubMed ID: 37522545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Glycolysis-Related Signature for Predicting the Prognosis and Immune Infiltration of Uveal Melanoma.
    Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C
    Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Versican as an Independent Prognostic Factor in Uveal Melanoma.
    Xu J; Zhao Y; Sun H; Xiao Q; Ye P
    Int J Gen Med; 2021; 14():4639-4651. PubMed ID: 34434056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and Functional Analysis of
    Mei S; Li Y; Kang X
    Dis Markers; 2022; 2022():4143447. PubMed ID: 35432628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma.
    Chi H; Peng G; Yang J; Zhang J; Song G; Xie X; Strohmer DF; Lai G; Zhao S; Wang R; Yang F; Tian G
    Front Endocrinol (Lausanne); 2022; 13():1056310. PubMed ID: 36568076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-omics approaches identify novel prognostic biomarkers of autophagy in uveal melanoma.
    Jin W; Wu L; Hu L; Fu Y; Fan Z; Mou Y; Ma K
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16691-16703. PubMed ID: 37725244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic values of Annexins and validation of the influence on cell proliferation, migration, and invasion in uveal melanoma.
    Zhao A; Wang Z; Wang Y; Chen X
    Am J Transl Res; 2023; 15(5):3131-3151. PubMed ID: 37303667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding tumor heterogeneity in uveal melanoma: basement membrane genes as novel biomarkers and therapeutic targets revealed by multi-omics approaches for cancer immunotherapy.
    Li Y; Cai H; Yang J; Xie X; Pei S; Wu Y; Zhang J; Song G; Zhang J; Zhang Q; Chi H; Yang G
    Front Pharmacol; 2023; 14():1264345. PubMed ID: 37822877
    [No Abstract]   [Full Text] [Related]  

  • 12. Tryptophan metabolism-related gene expression patterns: unveiling prognostic insights and immune landscapes in uveal melanoma.
    Wang J; Zhao T; Li B; Wei W
    Aging (Albany NY); 2023 Oct; 15(20):11201-11216. PubMed ID: 37844995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma.
    Yan J; Zhou B; Guo L; Chen Z; Zhang B; Liu S; Zhang W; Yu M; Xu Y; Xiao Y; Zhou J; Fan J; Li H; Ye Q
    Am J Cancer Res; 2020; 10(11):3705-3720. PubMed ID: 33294262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMT-Related Gene Signature Predicts the Prognosis in Uveal Melanoma Patients.
    Lv Y; He L; Jin M; Sun W; Tan G; Liu Z
    J Oncol; 2022; 2022():5436988. PubMed ID: 35990996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of B7 family and its association with tumor microenvironment in uveal melanoma.
    Chen Y; Zheng A; Zhang Y; Xiao M; Zhao Y; Wu X; Li M; Du F; Chen Y; Chen M; Li W; Li X; Sun Y; Gu L; Xiao Z; Shen J
    Front Immunol; 2022; 13():1026076. PubMed ID: 36311731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation.
    Ke MY; Xu T; Fang Y; Ye YP; Li ZJ; Ren FG; Lu SY; Zhang XF; Wu RQ; Lv Y; Dong J
    Cancer Lett; 2021 Aug; 513():14-25. PubMed ID: 33992711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of differentially expressed genes and functional annotations associated with metastases of the uveal melanoma.
    Xu Y; Han W; Xu WH; Wang Y; Yang XL; Nie HL; Yao J; Shen GL; Zhang XF
    J Cell Biochem; 2019 Nov; 120(11):19202-19214. PubMed ID: 31270856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Necroptosis-Related Prognostic Model of Uveal Melanoma Was Constructed by Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases.
    Xie J; Chen L; Tang Q; Wei W; Cao Y; Wu C; Hang J; Zhang K; Shi J; Wang M
    Front Immunol; 2022; 13():847624. PubMed ID: 35242144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated Analysis of Genes Associated With Immune Microenvironment and Distant Metastasis in Uveal Melanoma.
    Zhou W; Li J
    Front Cell Dev Biol; 2022; 10():874839. PubMed ID: 35433689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Immune Cell Infiltration Landscape and Their Prognostic Significance in Uveal Melanoma.
    Zhao H; Chen Y; Shen P; Gong L
    Front Cell Dev Biol; 2021; 9():713569. PubMed ID: 34513843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.